Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.713 | 0.861 | 0.99972 | 1.00000 | |
RegionR2 | 4.731 | 0.861 | 0.03653 | 0.22074 | |
RegionR3 | 1.189 | 0.861 | 0.28739 | 0.82990 | |
RegionR4 | -2.643 | 0.861 | 0.99964 | 1.00000 | |
RegionR5 | -1.559 | 0.861 | 0.99970 | 1.00000 | |
RegionR6 | 2.584 | 0.861 | 0.08132 | 0.52696 | |
RegionR7 | -0.791 | 0.861 | 0.99980 | 1.00000 | |
RegionR8 | -0.798 | 0.861 | 0.99980 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 1.691 | 0.861 | 0.99996 | 1.00000 | |
RegenerationR2 | 0.905 | 0.861 | 0.34749 | 0.78022 | |
RegenerationR3 | 2.516 | 0.861 | 0.15499 | 0.58552 | |
RegenerationR4 | 1.759 | 0.861 | 0.31555 | 0.75488 | |
RegenerationR5 | 2.867 | 0.861 | 0.06231 | 0.39617 | |
RegenerationR6 | -0.635 | 0.861 | 0.77850 | 0.96679 | |
RegenerationBL | -0.62 | 0.861 | 0.99988 | 1.00000 | |
RegenerationTP | 0.525 | 0.861 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_12438 | 17 | 0.35 | Mlig455_009594 | Neo: - Age: - |
4 | - | - | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_009594 {REF} {Length: 2044} {RNA1310_39190} {RNA815_29274} | |
2. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 3.465 | - | - | 0.737 | 0.952 | 0.861 | 0.915 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
3. | MligTC455_29412 | 46 | 0.96 | Mlig455_000627, Mlig455_008268, Mlig455_040614 | Neo: - Age: Up-Down-Up |
2.847 | - | - | - | 1.000 | 0.960 | 0.887 | Mlig455_000627 {REF} {Length: 1331} {RNA1310_62571} {RNA815_30942} Mlig455_008268 {REF} {Length: 1779} {RNA1509_47298} {RNA1310_98344} {RNA815_10804.1} Mlig455_040614 {REF} {Length: 1016} |
|
4. | MligTC455_43454 | 36 | 0.74 | Mlig455_043999 | Neo: - Age: - |
2.837 | - | - | - | 0.994 | 0.963 | 0.880 | Mlig455_043999 {REF} {Length: 2456} {Dmel: FBgn0259222, CG42322, [RH, Score=101, Expect=3e-22]} {Smed: dd_Smed_v6_18554_0_1, dd_Smed_v6_18554_0_1, [Score=82.4, Expect=1e-17]} {RNA1310_20749} {RNA815_38231} | |
5. | MligTC455_24197 | 48 | 1 | Mlig455_062645 | Neo: - Age: - |
KCNH7 | 2.835 | - | - | 0.981 | 0.993 | 0.861 | - | Mlig455_062645 {REF} {Length: 4615} {Pfam: Ion transport protein [PF00520.33, score=125.5]; Cyclic nucleotide-binding domain [PF00027.31, score=51.0]; Ion channel [PF07885.18, score=45.8]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [RH, Score=841, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [RH, Score=818, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [RH, Score=805, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [RH, Score=840, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [RH, Score=816, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [RH, Score=805, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [RH, Score=780, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [RH, Score=764, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [RH, Score=841, Expect=0.0]} {RNA1509_16542} {RNA1310_43827} {RNA815_26448} |
6. | MligTC455_25928 | 181 | 3.78 | Mlig455_006534, Mlig455_006538, Mlig455_006649, Mlig455_006700 | Neo: - Age: logFC(26M/2M)=-0.528 Region-specific R2: 7.256 Region-enriched R2: 5.788/0.02697 |
2.83 | - | - | - | 0.976 | 0.983 | 0.871 | Mlig455_006534 {REF} {Length: 689} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006538 {REF} {Length: 1691} {RNA1509_12380} {RNA1310_164.2} {RNA815_19957} Mlig455_006649 {REF} {Length: 829} {RNA1509_22927} {RNA1310_81957.1} {RNA815_41771.2} Mlig455_006700 {REF} {Length: 750} {RNA1509_22927} {RNA1310_81957.2} {RNA815_41771.2} |
|
7. | MligTC455_15329 | 22 | 0.47 | Mlig455_060498 | Neo: - Age: - |
2.811 | - | - | - | 0.969 | 0.947 | 0.895 | Mlig455_060498 {REF} {Length: 1186} {Pfam: PAN domain [PF00024.28, score=18.9]} {Smed: dd_Smed_v6_32483_0_1, dd_Smed_v6_32483_0_1, [Score=63.9, Expect=4e-12]} {RNA1310_37660} {RNA815_17816.1} | |
8. | MligTC455_19583 | 95 | 1.97 | Mlig455_010583, Mlig455_010602 | Neo: - Age: - Region-enriched R2: 6.442/0.00383 |
2.804 | - | - | - | 0.975 | 0.921 | 0.908 | Mlig455_010583 {REF} {Length: 2325} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=173.5]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [Score=320, Expect=4e-101]} {RNA1310_36131} {RNA815_32135} Mlig455_010602 {REF} {Length: 2432} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=182.9]} {Smed: dd_Smed_v6_15099_0_1, dd_Smed_v6_15099_0_1, [RH, Score=346, Expect=2e-110]} {RNA1310_36131} {RNA815_32135} |
|
9. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 2.799 | - | - | - | 0.902 | 0.987 | 0.910 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
10. | MligTC455_48064 | 23 | 0.48 | Mlig455_061550 | Neo: - Age: - |
2.799 | - | - | - | 0.990 | 0.982 | 0.827 | Mlig455_061550 {REF} {Length: 860} {RNA1310_88363} {RNA815_47885} | |
11. | MligTC455_19079 | 218 | 4.54 | Mlig455_008746, Mlig455_008760 | Neo: - Age: Down-Up-Up Region-specific R2: 6.705 Region-enriched R2: 6.864/0.00152 |
2.795 | - | - | - | 0.963 | 0.927 | 0.905 | Mlig455_008746 {REF} {Length: 652} {RNA1310_75395.1} {RNA815_42524} Mlig455_008760 {REF} {Length: 1051} {RNA1310_75395.1} {RNA815_42524} |
|
12. | MligTC455_11701 | 54 | 1.12 | Mlig455_042837, Mlig455_045855, Mlig455_045871 | Neo: - Age: - |
2.789 | - | - | - | 1.000 | 0.896 | 0.893 | Mlig455_042837 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045855 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} Mlig455_045871 {REF} {Length: 487} {RNA1310_85827} {RNA815_46819} |
|
13. | MligTC455_14598 | 52 | 1.07 | Mlig455_058970 | Neo: - Age: - |
2.785 | - | - | - | 0.906 | 0.968 | 0.911 | Mlig455_058970 {REF} {Length: 1038} {RNA1310_39570} {RNA815_52309} | |
14. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 2.784 | - | - | - | 0.966 | 0.913 | 0.905 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
15. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
2.782 | - | - | - | 0.989 | 0.887 | 0.906 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
16. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
2.78 | - | - | - | 0.998 | 0.868 | 0.914 | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
17. | MligTC455_26322 | 65 | 1.35 | Mlig455_042546 | Neo: - Age: - |
GRID2 | 2.776 | - | - | - | 0.990 | 0.880 | 0.906 | Mlig455_042546 {REF} {Length: 3217} {Pfam: Ligand-gated ion channel [PF00060.28, score=79.6]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=49.4]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=35.5]; Receptor family ligand binding region [PF01094.30, score=33.7]} {Human: ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=127, Expect=3e-29]} {Mouse: ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=129, Expect=5e-30]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=133, Expect=1e-31]} {Celegans: WBGene00001615, glr-4, GLutamate Receptor family (AMPA), [Score=105, Expect=6e-23]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=238, Expect=8e-71]} {RNA1310_27694} {RNA815_34664} |
18. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
2.776 | - | - | - | 0.998 | 0.940 | 0.838 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
19. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 2.771 | - | - | - | 0.970 | 0.925 | 0.876 | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
20. | MligTC455_46022 | 51 | 1.07 | Mlig455_009838 | Neo: - Age: - |
2.769 | - | - | 0.893 | 0.893 | 0.983 | - | Mlig455_009838 {REF} {Length: 1632} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=54.1]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.2]} {Dmel: FBgn0038874, ETHR, [Score=50.1, Expect=2e-06]} {Smed: dd_Smed_v6_17171_0_1, dd_Smed_v6_17171_0_1, [Score=175, Expect=2e-51]} {RNA1310_62858} {RNA815_33606} | |
21. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
2.768 | - | - | - | 0.997 | 0.872 | 0.899 | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
22. | MligTC455_27216 | 56 | 1.18 | Mlig455_022418 | Neo: - |
TRPM3 | 2.768 | - | - | - | 0.973 | 0.910 | 0.885 | Mlig455_022418 {REF} {Length: 4794} {Pfam: SLOG in TRPM [PF18139.3, score=136.8]; Ion transport protein [PF00520.33, score=41.0]; SLOG in TRPM, prokaryote [PF18171.3, score=34.2]} {Human: ENSG00000083067, TRPM3, transient receptor potential cation channel subfamily M member 3, [Score=317, Expect=2e-88]; ENSG00000119121, TRPM6, transient receptor potential cation channel subfamily M member 6, [Score=316, Expect=4e-88]} {Mouse: ENSMUSG00000052387, Trpm3, transient receptor potential cation channel, subfamily M, member 3, [Score=319, Expect=4e-90]} {Dmel: FBgn0265194, Trpm, Transient receptor potential cation channel, subfamily M, [Score=309, Expect=7e-88]} {Celegans: WBGene00001796, gtl-2, Gon-Two Like (TRP subfamily), [Score=255, Expect=4e-69]} {Smed: dd_Smed_v6_9288_0_1, dd_Smed_v6_9288_0_1, [Score=418, Expect=3e-126]} {RNA1509_17593} {RNA1310_1651, RNA1509_17593} {RNA1509_17593, RNA815_2281} |
23. | MligTC455_47420 | 218 | 4.54 | Mlig455_017159, Mlig455_048110 | Neo: - Age: - Region-specific R2: 6.469 Region-enriched R2: 5.851/0.00135 |
2.763 | - | - | - | 0.994 | 0.829 | 0.940 | Mlig455_017159 {REF} {Length: 1062} {RNA1509_35349} {RNA1310_81586} Mlig455_048110 {REF} {Length: 527} {RNA1310_81586} |
|
24. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
2.762 | - | - | - | 0.996 | 0.878 | 0.888 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
25. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
2.757 | - | - | - | 0.995 | 0.871 | 0.891 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
26. | MligTC455_49451 | 16 | 0.34 | Mlig455_030374 | Neo: - Age: - |
NOX5 | 2.757 | - | - | - | 0.957 | 0.907 | 0.893 | Mlig455_030374 {REF} {Length: 890} {Pfam: EF hand [PF00036.34, score=93.4]; EF-hand domain [PF13405.8, score=86.0]; EF hand [PF13202.8, score=73.1]; EF-hand domain pair [PF13499.8, score=70.3]; EF-hand domain pair [PF13833.8, score=49.3]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=29.0]; EF-hand domain [PF14658.8, score=23.2]; Caleosin related protein [PF05042.15, score=20.4]; EF-hand domain [PF17958.3, score=19.8]} {Human: ENSG00000255346, NOX5, NADPH oxidase 5, [Score=67.4, Expect=2e-13]} {Mouse: ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.5, Expect=3e-13]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=63.2, Expect=4e-13]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=63.2, Expect=4e-13]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=63.2, Expect=4e-13]} {Dmel: FBgn0033238, azot, ahuizotl, [Score=64.3, Expect=1e-13]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=62.4, Expect=6e-13]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=101, Expect=2e-28]} {RNA1310_74457} |
27. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
2.755 | - | - | - | 0.996 | 0.866 | 0.893 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
28. | MligTC455_46452 | 134 | 2.79 | Mlig455_048151 | Neo: - Age: - Region-specific R2: 6.389 Region-enriched R2: 7.075/0.00014 Regeneration-downregulated R2: -3.162 Regeneration-depleted R2: -3.162 |
2.752 | - | - | - | 0.995 | 0.890 | 0.867 | Mlig455_048151 {REF} {Length: 618} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=25.7]} {RNA1310_62963} {RNA815_31352} | |
29. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
2.749 | - | - | - | 0.984 | 0.849 | 0.916 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
30. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 2.748 | - | - | - | 0.970 | 0.874 | 0.904 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
31. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 2.747 | - | - | - | 0.909 | 0.974 | 0.864 | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
32. | MligTC455_41967 | 159 | 3.32 | Mlig455_017184 | Neo: Int S/G2/M Age: Down-Up-Up Region-enriched R2: 7.330/0.00001 |
2.745 | - | - | - | 0.985 | 0.851 | 0.909 | Mlig455_017184 {REF} {Length: 1106} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.0]} {RNA1509_40628} {RNA1310_50753, RNA1509_40628} {RNA1509_40628, RNA815_21607} | |
33. | MligTC455_19552 | 288 | 6 | Mlig455_055936, Mlig455_068188 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.424 Region-specific R2: 6.302 Region-enriched R2: 4.919/0.00633 Regeneration-depleted R4: -5.607 |
2.744 | - | - | - | 0.996 | 0.863 | 0.885 | Mlig455_055936 {REF} {Length: 665} {RNA1310_71052} {RNA815_36745} Mlig455_068188 {REF} {Length: 714} {RNA1310_71052} {RNA815_36745} |
|
34. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
2.743 | - | - | - | 0.996 | 0.854 | 0.893 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
35. | MligTC455_52629 | 472 | 9.83 | Mlig455_059435 | Neo: - Age: Down-Up-Up Region-specific R2: 6.775 Region-enriched R2: 6.727/0.00002 |
2.741 | - | - | - | 0.999 | 0.849 | 0.893 | Mlig455_059435 {REF} {Length: 726} {RNA1509_48505} {RNA1310_62885} {RNA815_39881} | |
36. | MligTC455_16974 | 15 | 0.32 | Mlig455_052824 | Neo: - Age: - |
2.74 | - | - | 0.886 | 0.999 | 0.855 | - | Mlig455_052824 {REF} {Length: 306} {NoTransDecoderORF} {RNA1310_65069} {RNA815_35708.2} | |
37. | MligTC455_51334 | 326 | 6.78 | Mlig455_011442, Mlig455_061180 | Neo: - |
2.74 | - | - | - | 0.996 | 0.853 | 0.891 | Mlig455_011442 {REF} {Length: 742} {RNA1310_57576.1} {RNA815_29867} Mlig455_061180 {REF} {Length: 769} {RNA1310_57576.1} {RNA815_29867} |
|
38. | MligTC455_15836 | 36 | 0.74 | Mlig455_000292 | Neo: - Age: Up-Down-Down |
PLEKHG5 | 2.735 | - | - | - | 0.901 | 0.976 | 0.858 | Mlig455_000292 {REF} {Length: 4512} {Pfam: RhoGEF domain [PF00621.22, score=89.5]; PH domain [PF17838.3, score=20.5]; Pleckstrin homology domain [PF15405.8, score=19.2]} {Human: ENSG00000171680, PLEKHG5, pleckstrin homology and RhoGEF domain containing G5, [Score=197, Expect=6e-52]} {Mouse: ENSMUSG00000039713, Plekhg5, pleckstrin homology domain containing, family G (with RhoGef domain) member 5, [Score=199, Expect=5e-53]} {Dmel: FBgn0261556, CG42674, [Score=147, Expect=6e-36]} {Celegans: WBGene00006476, rhgf-2, RHGF-2; RHo Guanine nucleotide exchange Factor, [RH, Score=147, Expect=3e-36]} {Smed: dd_Smed_v6_10072_0_1, dd_Smed_v6_10072_0_1, [RH, Score=179, Expect=8e-48]} {RNA1310_47096} {RNA815_53026} |
39. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 2.735 | - | - | - | 0.966 | 0.882 | 0.887 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
40. | MligTC455_38355 | 110 | 2.29 | Mlig455_039715, Mlig455_039769 | Neo: - Age: - |
KCNB2 | 2.735 | - | - | - | 0.896 | 0.987 | 0.852 | Mlig455_039715 {REF} {Length: 3883} {Pfam: Ion transport protein [PF00520.33, score=114.4]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=218, Expect=3e-60]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=213, Expect=2e-60]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=213, Expect=7e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=210, Expect=2e-59]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=209, Expect=7e-59]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=219, Expect=5e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=218, Expect=1e-60]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=214, Expect=8e-61]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=213, Expect=6e-60]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=230, Expect=8e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=236, Expect=3e-69]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=592, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} Mlig455_039769 {REF} {Length: 4176} {Pfam: Ion transport protein [PF00520.33, score=116.7]; BTB/POZ domain [PF02214.24, score=75.0]; Ion channel [PF07885.18, score=43.6]; Polycystin cation channel [PF08016.14, score=20.7]} {Human: ENSG00000182674, KCNB2, potassium voltage-gated channel subfamily B member 2, [Score=219, Expect=8e-61]; ENSG00000129159, KCNC1, potassium voltage-gated channel subfamily C member 1, [Score=216, Expect=2e-61]; ENSG00000158445, KCNB1, potassium voltage-gated channel subfamily B member 1, [Score=215, Expect=2e-59]; ENSG00000166006, KCNC2, potassium voltage-gated channel subfamily C member 2, [Score=213, Expect=2e-60]; ENSG00000116396, KCNC4, potassium voltage-gated channel subfamily C member 4, [Score=213, Expect=4e-60]; ENSG00000131398, KCNC3, potassium voltage-gated channel subfamily C member 3, [Score=210, Expect=4e-58]} {Mouse: ENSMUSG00000092083, Kcnb2, potassium voltage gated channel, Shab-related subfamily, member 2, [Score=221, Expect=2e-61]; ENSMUSG00000050556, Kcnb1, potassium voltage gated channel, Shab-related subfamily, member 1, [Score=219, Expect=4e-61]; ENSMUSG00000058975, Kcnc1, potassium voltage gated channel, Shaw-related subfamily, member 1, [Score=216, Expect=6e-62]; ENSMUSG00000035681, Kcnc2, potassium voltage gated channel, Shaw-related subfamily, member 2, [Score=215, Expect=6e-61]; ENSMUSG00000062785, Kcnc3, potassium voltage gated channel, Shaw-related subfamily, member 3, [Score=211, Expect=1e-58]} {Dmel: FBgn0003386, Shaw, Shaker cognate w, [Score=231, Expect=2e-67]} {Celegans: WBGene00008819, shw-1, SHaW family of potassium channels, [Score=239, Expect=2e-70]} {Smed: dd_Smed_v6_11886_0_1, dd_Smed_v6_11886_0_1, [RH, Score=595, Expect=0.0]} {RNA1509_22940} {RNA1310_17926} {RNA815_8687.1} |
41. | MligTC455_43714 | 152 | 3.18 | Mlig455_000684, Mlig455_000736 | Neo: - Age: - |
2.735 | - | - | - | 0.999 | 0.842 | 0.894 | Mlig455_000684 {REF} {Length: 796} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} Mlig455_000736 {REF} {Length: 797} {Pfam: WSC domain [PF01822.21, score=42.8]} {RNA1310_46313} {RNA815_23250} |
|
42. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
2.732 | - | - | - | 0.999 | 0.832 | 0.901 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
43. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 2.732 | - | - | - | 0.992 | 0.888 | 0.852 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
44. | MligTC455_45021 | 381 | 7.95 | Mlig455_046686 | Neo: - Age: Down-Up-Up Region-enriched R2: 3.428/0.03156 |
AVP | 2.73 | - | - | - | 0.956 | 0.876 | 0.898 | Mlig455_046686 {REF} {Length: 1388} {Pfam: Neurohypophysial hormones, C-terminal Domain [PF00184.19, score=36.2]} {Human: ENSG00000101200, AVP, arginine vasopressin, [Score=54.3, Expect=2e-09]} {Mouse: ENSMUSG00000037727, Avp, arginine vasopressin, [Score=53.1, Expect=3e-09]} {RNA1509_50574} {RNA1310_38922} {RNA815_23813} |
45. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 2.728 | - | - | - | 0.996 | 0.847 | 0.885 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
46. | MligTC455_15883 | 95 | 1.98 | Mlig455_020080, Mlig455_040893 | Neo: - Age: - |
2.727 | - | - | - | 0.947 | 0.974 | 0.806 | Mlig455_020080 {REF} {Length: 1487} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=20.9]} {RNA1310_27849} {RNA815_37376} Mlig455_040893 {REF} {Length: 1486} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=21.0]} {RNA1310_27849} {RNA815_37376} |
|
47. | MligTC455_46451 | 229 | 4.76 | Mlig455_017183 | Neo: - Age: Down-Up-Down Region-specific R2: 5.510 Region-enriched R2: 5.394/0.00018 Regeneration-downregulated R2: -2.986 Regeneration-depleted R2: -2.986 |
2.723 | - | - | - | 0.994 | 0.851 | 0.878 | Mlig455_017183 {REF} {Length: 657} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.6]} {RNA1310_62963} {RNA815_31352} | |
48. | MligTC455_52164 | 49 | 1.01 | Mlig455_019248 | Neo: - Age: Down-Up-Up Region-enriched R1: 12.972/0.02781 |
2.715 | - | - | - | 0.921 | 0.965 | 0.829 | Mlig455_019248 {REF} {Length: 923} {Celegans: WBGene00015646, mlt-10, [Score=98.2, Expect=4e-23]} {RNA1509_24360} {RNA1310_75398} {RNA815_40298} | |
49. | MligTC455_17895 | 389 | 8.1 | Mlig455_060774 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.268 Region-specific R2: 7.424 Region-enriched R2: 6.488/0.00062 Regeneration-downregulated R2: -4.133 Regeneration-depleted R2: -4.133 |
2.714 | - | - | - | 1.000 | 0.904 | 0.810 | Mlig455_060774 {REF} {Length: 1670} {RNA1509_34403} {RNA1310_35901, RNA1509_34403} {RNA1509_34403, RNA815_35590} | |
50. | MligTC455_51177 | 76 | 1.59 | Mlig455_058323 | Neo: - Age: Down-Up-Up |
SAXO1 | 2.714 | - | - | - | 0.890 | 0.993 | 0.831 | Mlig455_058323 {REF} {Length: 1875} {Human: ENSG00000155875, SAXO1, stabilizer of axonemal microtubules 1, [Score=48.1, Expect=1e-05]} {Smed: dd_Smed_v6_70006_0_1, dd_Smed_v6_70006_0_1, [Score=60.8, Expect=5e-11]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
51. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 2.713 | - | - | - | 0.987 | 0.825 | 0.901 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
52. | MligTC455_18945 | 41 | 0.86 | Mlig455_031602 | Neo: - Age: - |
2.712 | - | - | - | 0.999 | 0.820 | 0.893 | Mlig455_031602 {REF} {Length: 914} {RNA1310_75361} {RNA815_24378} | |
53. | MligTC455_43715 | 48 | 0.99 | Mlig455_034191 | Neo: - Age: Down-Up-Down Region-enriched R2: 7.969/0.00817 |
2.711 | - | - | - | 0.994 | 0.824 | 0.893 | Mlig455_034191 {REF} {Length: 895} {Pfam: WSC domain [PF01822.21, score=39.9]; PAN domain [PF14295.8, score=21.0]; PAN domain [PF00024.28, score=19.9]} {RNA1310_46313} {RNA815_23250} | |
54. | MligTC455_12847 | 25 | 0.51 | Mlig455_049599 | Neo: - Age: - |
2.71 | - | - | - | 0.972 | 0.780 | 0.958 | Mlig455_049599 {REF} {Length: 1963} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=67.4]; Olfactory receptor [PF13853.8, score=24.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=20.1]} {Dmel: FBgn0053696, CNMaR, CNMamide Receptor, [RH, Score=91.7, Expect=1e-19]} {Smed: dd_Smed_v6_35525_0_1, dd_Smed_v6_35525_0_1, [Score=144, Expect=1e-38]} {RNA1310_85894} {RNA815_45174} | |
55. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 2.709 | - | - | - | 0.997 | 0.810 | 0.902 | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
56. | MligTC455_11558 | 137 | 2.85 | Mlig455_058259 | Neo: - Age: logFC(26M/2M)=-0.792 |
2.707 | - | - | - | 0.998 | 0.865 | 0.844 | Mlig455_058259 {REF} {Length: 896} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=19.9]} {RNA1509_58923} {RNA1310_41706, RNA1509_58923} {RNA1509_58923, RNA815_20876} | |
57. | MligTC455_07826 | 23 | 0.48 | Mlig455_056551 | Neo: - Age: - |
2.702 | - | - | 0.796 | 0.997 | 0.909 | - | Mlig455_056551 {REF} {Length: 3263} {Pfam: PH domain [PF00169.31, score=23.0]} {RNA1310_46895.1} {RNA815_27323} | |
58. | MligTC455_13846 | 32 | 0.67 | Mlig455_013761 | Neo: - Age: - |
CALM2 | 2.698 | - | - | - | 0.987 | 0.855 | 0.856 | Mlig455_013761 {REF} {Length: 941} {Pfam: EF hand [PF00036.34, score=94.2]; EF-hand domain [PF13405.8, score=86.1]; EF-hand domain pair [PF13499.8, score=83.6]; EF hand [PF13202.8, score=77.1]; EF-hand domain pair [PF13833.8, score=42.5]; Secreted protein acidic and rich in cysteine Ca binding region [PF10591.11, score=31.3]; EF-hand domain [PF14658.8, score=23.8]; Ca2+ insensitive EF hand [PF08726.12, score=21.5]; Caleosin related protein [PF05042.15, score=21.3]} {Human: ENSG00000143933, CALM2, calmodulin 2, [Score=60.1, Expect=1e-11]; ENSG00000160014, CALM3, calmodulin 3, [Score=60.1, Expect=1e-11]; ENSG00000198668, CALM1, calmodulin 1, [Score=60.1, Expect=1e-11]; ENSG00000178363, CALML3, calmodulin like 3, [Score=59.3, Expect=2e-11]} {Mouse: ENSMUSG00000001175, Calm1, calmodulin 1, [Score=60.5, Expect=1e-11]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=60.1, Expect=8e-12]; ENSMUSG00000019370, Calm3, calmodulin 3, [Score=60.1, Expect=8e-12]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=59.7, Expect=1e-11]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=60.8, Expect=3e-12]} {Celegans: WBGene00019352, K03A1.4, [Score=70.9, Expect=8e-16]} {Smed: dd_Smed_v6_15455_0_1, dd_Smed_v6_15455_0_1, [RH, Score=97.4, Expect=1e-26]} {RNA1310_47452} {RNA815_31258} |
59. | MligTC455_37682 | 225 | 4.68 | Mlig455_022978, Mlig455_023072 | Neo: - Age: Up-Down-Up Region-enriched R7: 2.657/0.03586 |
KCNN2 | 2.697 | - | - | - | 0.870 | 0.969 | 0.858 | Mlig455_022978 {REF} {Length: 4236} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.8]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=548, Expect=0.0]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=539, Expect=1e-180]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=549, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=541, Expect=0.0]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=637, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=424, Expect=5e-135]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=572, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1, RNA1509_28013} {RNA1509_28013, RNA815_7768} Mlig455_023072 {REF} {Length: 3426} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=149.3]; Calmodulin binding domain [PF02888.18, score=116.0]; Ion channel [PF07885.18, score=49.6]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=534, Expect=3e-177]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=525, Expect=2e-175]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=536, Expect=1e-178]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=528, Expect=1e-176]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=627, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=410, Expect=8e-130]} {Smed: dd_Smed_v6_15620_0_1, dd_Smed_v6_15620_0_1, [RH, Score=559, Expect=0.0]} {RNA1509_28013} {RNA1310_5308.1} {RNA815_7768} |
60. | MligTC455_26356 | 62 | 1.3 | Mlig455_042551 | Neo: - |
GRIK2 | 2.696 | - | - | - | 0.970 | 0.833 | 0.893 | Mlig455_042551 {REF} {Length: 2917} {Pfam: Ligand-gated ion channel [PF00060.28, score=82.2]; Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=60.7]; Receptor family ligand binding region [PF01094.30, score=32.2]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=27.3]} {Human: ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=144, Expect=9e-35]; ENSG00000152208, GRID2, glutamate ionotropic receptor delta type subunit 2, [Score=141, Expect=7e-34]} {Mouse: ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000071424, Grid2, glutamate receptor, ionotropic, delta 2, [Score=142, Expect=2e-34]} {Dmel: FBgn0051201, GluRIIE, Glutamate receptor IIE, [Score=119, Expect=3e-27]} {Celegans: WBGene00001616, glr-5, GLutamate Receptor family (AMPA), [Score=123, Expect=2e-28]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=247, Expect=4e-74]} {RNA1310_21865} {RNA815_26044} |
61. | MligTC455_50455 | 972 | 20.25 | Mlig455_070346 | Neo: - Age: - Region-specific R2: 4.855 Region-enriched R2: 5.186/0.00000 |
2.694 | - | - | - | 0.975 | 0.825 | 0.894 | Mlig455_070346 {REF} {Length: 932} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=34.4]; Nematode insulin-related peptide beta type [PF03488.16, score=21.4]} {RNA1509_18514, RNA1509_58074} {RNA1310_51990, RNA1509_18514, RNA1509_58074} {RNA1509_18514, RNA1509_58074, RNA815_25071} | |
62. | MligTC455_51179 | 75 | 1.55 | Mlig455_068660 | Neo: - Age: - |
WEE2 | 2.692 | - | - | - | 0.890 | 0.994 | 0.808 | Mlig455_068660 {REF} {Length: 3046} {TRANSSPLICED} {Pfam: Protein kinase domain [PF00069.27, score=86.3]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=55.7]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=19.4]} {Human: ENSG00000263042, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]; ENSG00000214102, WEE2, WEE1 homolog 2, [Score=102, Expect=6e-22]} {Mouse: ENSMUSG00000037159, Wee2, WEE1 homolog 2 (S. pombe), [Score=102, Expect=2e-22]} {Dmel: FBgn0040298, Myt1, [Score=82.0, Expect=6e-16]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=65.1, Expect=1e-10]} {Smed: dd_Smed_v6_17244_0_1, dd_Smed_v6_17244_0_1, [Score=73.9, Expect=1e-13]} {RNA1509_36492} {RNA1310_14560} {RNA815_5366} |
63. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
2.691 | - | - | - | 1.000 | 0.795 | 0.896 | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
64. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 2.69 | - | - | - | 0.990 | 0.854 | 0.846 | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
65. | MligTC455_10082 | 430 | 8.96 | Mlig455_000403, Mlig455_000471 | Neo: - Age: - Region-enriched R2: 2.917/0.00040 |
2.689 | - | - | - | 0.993 | 0.951 | 0.745 | Mlig455_000403 {REF} {Length: 747} {RNA1310_48386} {RNA815_37422} Mlig455_000471 {REF} {Length: 750} {RNA1310_48386} {RNA815_37422} |
|
66. | MligTC455_18748 | 104 | 2.17 | Mlig455_024985, Mlig455_024999 | Neo: - Age: - Region-enriched R2: 6.002/0.00016 |
GRIK4 | 2.683 | - | - | - | 1.000 | 0.803 | 0.880 | Mlig455_024985 {REF} {Length: 1514} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_47299} {RNA815_38321} Mlig455_024999 {REF} {Length: 3567} {Pfam: Ligand-gated ion channel [PF00060.28, score=76.7]; Receptor family ligand binding region [PF01094.30, score=31.5]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=20.6]} {Human: ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=122, Expect=1e-27]} {Mouse: ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=124, Expect=1e-28]} {Dmel: FBgn0038837, CG3822, [Score=120, Expect=1e-27]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=99.0, Expect=5e-21]} {Smed: dd_Smed_v6_21015_0_1, dd_Smed_v6_21015_0_1, [Score=196, Expect=2e-55]} {RNA1509_35538} {RNA1310_7578, RNA1509_35538} {RNA1509_35538, RNA815_4987} |
67. | MligTC455_17578 | 447 | 9.32 | Mlig455_010738 | Neo: - Age: Down-Up-Up Region-specific R2: 8.320 Region-enriched R2: 9.793/0.00000 |
2.682 | - | - | - | 1.000 | 0.800 | 0.882 | Mlig455_010738 {REF} {Length: 642} {RNA1509_48297, RNA1509_55742} {RNA1310_84623, RNA1509_48297, RNA1509_55742} {RNA1509_48297, RNA1509_55742, RNA815_45356} | |
68. | MligTC455_38162 | 710 | 14.8 | Mlig455_045004 | Neo: - Age: Down-Up-Up Region-specific R2: 5.269 Region-enriched R2: 5.838/0.00000 Regeneration-downregulated R2: -4.412 Regeneration-depleted R2: -4.412 |
2.678 | - | - | - | 0.970 | 0.823 | 0.885 | Mlig455_045004 {REF} {Length: 659} {Smed: dd_Smed_v6_4046_0_1, dd_Smed_v6_4046_0_1, [Score=57.8, Expect=2e-12]} {RNA1509_50998, RNA1509_57106} {RNA1310_56015, RNA1509_50998, RNA1509_57106} {RNA1509_50998, RNA1509_57106, RNA815_29915} | |
69. | MligTC455_49825 | 543 | 11.31 | Mlig455_069114 | Neo: - Age: Down-Up-Up Region-specific R2: 4.806 Region-enriched R2: 3.936/0.00000 |
2.677 | - | - | - | 0.969 | 0.796 | 0.912 | Mlig455_069114 {REF} {Length: 828} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [Score=40.0, Expect=9e-06]} {RNA1509_26665} {RNA1310_48731, RNA1509_26665} {RNA1509_26665, RNA815_24488} | |
70. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
2.673 | - | - | 0.831 | 0.996 | 0.846 | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
71. | MligTC455_53720 | 144 | 2.99 | Mlig455_028516 | Neo: - Age: - Region-enriched R2: 4.205/0.01762 |
CTBP2 | 2.672 | - | - | - | 0.952 | 0.880 | 0.840 | Mlig455_028516 {REF} {Length: 3357} {TRANSSPLICED} {Pfam: D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain [PF02826.21, score=112.7]; D-isomer specific 2-hydroxyacid dehydrogenase, catalytic domain [PF00389.32, score=67.2]; THAP domain [PF05485.14, score=38.8]; NAD binding domain of 6-phosphogluconate dehydrogenase [PF03446.17, score=22.2]} {Human: ENSG00000175029, CTBP2, C-terminal binding protein 2, [Score=370, Expect=3e-115]; ENSG00000159692, CTBP1, C-terminal binding protein 1, [Score=360, Expect=1e-117]} {Mouse: ENSMUSG00000030970, Ctbp2, C-terminal binding protein 2, [Score=372, Expect=5e-116]; ENSMUSG00000037373, Ctbp1, C-terminal binding protein 1, [Score=362, Expect=8e-119]} {Dmel: FBgn0020496, CtBP, C-terminal Binding Protein, [Score=354, Expect=1e-116]} {Celegans: WBGene00006424, ctbp-1, C-terminal-binding protein 1, [Score=475, Expect=8e-159]} {Smed: dd_Smed_v6_1063_0_1, dd_Smed_v6_1063_0_1, [Score=354, Expect=3e-115]} {RNA1310_37204} {RNA815_48484} |
72. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
2.668 | - | - | 0.814 | 1.000 | 0.854 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
73. | MligTC455_18505 | 15 | 0.31 | Mlig455_017536 | Neo: - Age: - |
2.668 | - | - | 0.741 | 0.979 | 0.948 | - | Mlig455_017536 {REF} {Length: 2174} {RNA1310_61282} {RNA815_41334} | |
74. | MligTC455_51009 | 16 | 0.33 | Mlig455_057754 | Neo: - Age: - |
2.666 | - | - | 0.809 | 0.964 | - | 0.893 | Mlig455_057754 {REF} {Length: 198} {NoTransDecoderORF} | |
75. | MligTC455_48756 | 622 | 12.96 | Mlig455_054772, Mlig455_054799, Mlig455_054893 | Neo: - Age: - Region-specific R2: 7.873 Region-enriched R2: 9.003/0.00000 |
2.663 | - | - | - | 0.981 | 0.785 | 0.897 | Mlig455_054772 {REF} {Length: 716} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054799 {REF} {Length: 625} {RNA1509_41507} {RNA1310_49516} {RNA815_28703} Mlig455_054893 {REF} {Length: 947} {RNA1509_41507} {RNA1310_49516, RNA1509_41507} {RNA1509_41507, RNA815_28703} |
|
76. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
2.662 | - | - | - | 0.991 | 0.778 | 0.893 | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
77. | MligTC455_10083 | 397 | 8.27 | Mlig455_000410, Mlig455_000477 | Neo: - Age: logFC(26M/2M)=1.533 Region-enriched R2: 3.033/0.00070 |
2.661 | - | - | - | 0.991 | 0.955 | 0.715 | Mlig455_000410 {REF} {Length: 1205} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} Mlig455_000477 {REF} {Length: 1206} {RNA1509_50537} {RNA1310_48386} {RNA815_37422} |
|
78. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
2.661 | - | - | - | 0.973 | 0.873 | 0.815 | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
79. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
2.648 | - | - | - | 0.957 | 0.799 | 0.892 | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
80. | MligTC455_17177 | 103 | 2.15 | Mlig455_048992, Mlig455_049009 | Neo: - Age: Down-Down-Up |
2.648 | - | - | - | 0.993 | 0.762 | 0.893 | Mlig455_048992 {REF} {Length: 1836} {RNA1509_44702} {RNA1310_14743, RNA1509_44702} {RNA1509_44702, RNA815_20669.1} Mlig455_049009 {REF} {Length: 1823} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} |
|
81. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
2.643 | - | - | - | 0.993 | 0.765 | 0.885 | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
82. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 2.642 | - | - | 0.741 | 0.983 | - | 0.918 | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
83. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 2.642 | - | - | - | 0.964 | 0.846 | 0.832 | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
84. | MligTC455_46188 | 25 | 0.51 | Mlig455_039664, Mlig455_039727 | Neo: - Age: - |
2.641 | - | - | - | 0.757 | 0.991 | 0.893 | Mlig455_039664 {REF} {Length: 1353} Mlig455_039727 {REF} {Length: 1348} |
|
85. | MligTC455_43173 | 392 | 8.16 | Mlig455_037383 | Neo: - Age: Up-Down-Down Regeneration-downregulated TP: -5.031 Regeneration-depleted TP: -5.031 |
C2orf16 | 2.639 | - | - | - | 0.962 | 0.752 | 0.925 | Mlig455_037383 {REF} {Length: 2450} {Pfam: Cornifin (SPRR) family [PF02389.17, score=23.4]} {Human: ENSG00000221843, C2orf16, chromosome 2 open reading frame 16, [Score=80.1, Expect=7e-15]} {RNA1509_52401} {RNA1310_14622.1} {RNA815_17994} |
86. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
2.638 | - | - | - | 0.995 | 0.873 | 0.770 | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
87. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
2.636 | - | - | - | 0.992 | 0.707 | 0.937 | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
88. | MligTC455_12183 | 53 | 1.11 | Mlig455_004166, Mlig455_004190 | Neo: - Age: - Region-enriched R2: 4.930/0.01881 |
2.635 | - | - | - | 0.982 | 0.829 | 0.824 | Mlig455_004166 {REF} {Length: 2818} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=57.4]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=29.1]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=55.5, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=8e-12]} {RNA1310_64973} {RNA815_58453} Mlig455_004190 {REF} {Length: 2742} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=56.7]; Serpentine type 7TM GPCR chemoreceptor Srbc [PF10316.11, score=28.6]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=56.2, Expect=1e-08]} {Smed: dd_Smed_v6_70862_0_1, dd_Smed_v6_70862_0_1, [Score=60.8, Expect=1e-11]} {RNA1310_62602} {RNA815_58453} |
|
89. | MligTC455_44354 | 1240 | 25.82 | Mlig455_001577 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.349 Region-specific R2: 5.143 Region-enriched R2: 4.498/0.00000 Regeneration-downregulated R2: -2.807 Regeneration-depleted R2: -2.807 |
2.633 | - | - | - | 0.955 | 0.886 | 0.792 | Mlig455_001577 {REF} {Length: 1028} {RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1310_49541.2, RNA1509_23470, RNA1509_33941, RNA1509_57202} {RNA1509_23470, RNA1509_33941, RNA1509_57202, RNA815_59782} | |
90. | MligTC455_38949 | 105 | 2.19 | Mlig455_065209 | Neo: - Age: - Region-specific R2: 7.633 Region-enriched R2: 10.088/0.00000 |
2.631 | - | - | - | 1.000 | 0.732 | 0.899 | Mlig455_065209 {REF} {Length: 591} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=23.2]} {RNA1509_44618} {RNA1310_63839, RNA1509_44618} {RNA1509_44618, RNA815_35329} | |
91. | MligTC455_50594 | 440 | 9.18 | Mlig455_010362 | Neo: - Age: Down-Up-Up Region-specific R2: 4.701 Region-enriched R2: 4.104/0.00000 |
2.631 | - | - | - | 0.960 | 0.871 | 0.800 | Mlig455_010362 {REF} {Length: 685} {RNA1509_30018} {RNA1310_56512.2} {RNA815_28562} | |
92. | MligTC455_43210 | 1513 | 31.51 | Mlig455_059969 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.253 Region-specific R2: 4.268 Region-enriched R2: 4.051/0.00000 |
2.63 | - | - | - | 0.974 | 0.837 | 0.819 | Mlig455_059969 {REF} {Length: 1263} {Pfam: Pancreatic hormone peptide [PF00159.20, score=46.6]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=41.6, Expect=1e-05]} {RNA1509_21159, RNA1509_26888, RNA1509_32920} {RNA1310_28339, RNA1509_21159, RNA1509_26888, RNA1509_32920} {RNA1509_21159, RNA1509_26888, RNA1509_32920, RNA815_20007.1} | |
93. | MligTC455_45351 | 241 | 5.02 | Mlig455_031191 | Neo: - Age: Down-Up-Down Region-enriched R2: 4.622/0.00310 |
2.628 | - | - | - | 0.991 | 0.812 | 0.825 | Mlig455_031191 {REF} {Length: 2855} {Pfam: Srg family chemoreceptor [PF02118.23, score=28.1]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=26.4]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=26.4]} {Celegans: WBGene00019019, frpr-10, FMRFamide Peptide Receptor family, [Score=49.3, Expect=2e-06]} {Smed: dd_Smed_v6_7534_0_1, dd_Smed_v6_7534_0_1, [Score=54.7, Expect=4e-08]} {RNA1509_20184} {RNA1310_32455} {RNA815_38062} | |
94. | MligTC455_44999 | 2214 | 46.12 | Mlig455_067394, Mlig455_069538 | Neo: - Age: Down-Up-Up Region-enriched R2: 2.840/0.00027 |
2.624 | - | - | - | 0.928 | 0.961 | 0.735 | Mlig455_067394 {REF} {Length: 401} {RNA1509_52966} {RNA1310_68651, RNA1509_52966} {RNA1509_52966, RNA815_33112.1} Mlig455_069538 {REF} {Length: 1759} {Celegans: WBGene00001446, flp-3, FMRFamide-like neuropeptides 3 SPLGTMRF-amide TPLGTMRF-amide SAEPFGTMRF-amide NPENDTPFGTMRF-amide ASEDALFGTMRF-amide EAEEPLGTMRF-amide SADDSAPFGTMRF-amide NPLGTMRF-amide, [Score=45.8, Expect=1e-06]} {RNA1509_13671} {RNA1310_56061} {RNA815_33112.1} |
|
95. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 2.621 | - | - | 0.731 | 1.000 | 0.890 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
96. | MligTC455_34810 | 109 | 2.27 | Mlig455_024348, Mlig455_024465 | Neo: - Age: - Region-enriched R2: 5.365/0.04615 |
2.621 | - | - | - | 0.981 | 0.851 | 0.789 | Mlig455_024348 {REF} {Length: 934} {RNA1310_67817} {RNA815_52313} Mlig455_024465 {REF} {Length: 1036} {RNA1310_67817} {RNA815_52313} |
|
97. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 2.602 | - | - | 0.741 | 1.000 | 0.861 | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
98. | MligTC455_48063 | 63 | 1.31 | Mlig455_046268 | Neo: - Age: - Region-enriched R2: 5.256/0.00170 |
2.602 | - | - | - | 0.981 | 0.903 | 0.718 | Mlig455_046268 {REF} {Length: 749} {RNA1310_88363} {RNA815_47885} | |
99. | MligTC455_44661 | 48 | 1 | Mlig455_038182 | Neo: - Age: logFC(26M/2M)=-0.564 |
ANO7 | 2.595 | - | - | 0.734 | 0.961 | 0.900 | - | Mlig455_038182 {REF} {Length: 3290} {Pfam: Calcium-activated chloride channel [PF04547.14, score=599.2]; Dimerisation domain of Ca+-activated chloride-channel, anoctamin [PF16178.7, score=223.8]} {Human: ENSG00000146205, ANO7, anoctamin 7, [Score=582, Expect=0.0]} {Mouse: ENSMUSG00000034107, Ano7, anoctamin 7, [Score=572, Expect=0.0]} {Dmel: FBgn0038721, subdued, [Score=422, Expect=3e-132]} {Celegans: WBGene00010138, anoh-1, Anoctamin, [Score=163, Expect=4e-41]} {Smed: dd_Smed_v6_19189_0_1, dd_Smed_v6_19189_0_1, [Score=670, Expect=0.0]} {RNA1509_46639} {RNA1310_1412.2} {RNA815_15650} |
100. | MligTC455_13042 | 15 | 0.3 | Mlig455_019940, Mlig455_020013 | Neo: - Age: - |
2.59 | - | - | - | 0.980 | 0.717 | 0.893 | Mlig455_019940 {REF} {Length: 1248} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=35.1]} {RNA1310_131593} {RNA815_62907} Mlig455_020013 {REF} {Length: 1183} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.2]} {RNA1310_131593} {RNA815_62907} |